Subscribe to the BioNews newsletter for free

Advanced Search

Search for

Like the Progress Educational Trust on Facebook



Gene patent

A patent on a specific gene sequence, its chemical composition, and/or processes for obtaining or using it.

Articles using this Glossary Item


Video Review: TED talk - Should you be able to patent a human gene?

14 March 2016 - by Ryan Ross

Tania Simoncelli's narrates the story of the successful legal challenge against Myriad Genetics' BRCA patents, but may have missed an opportunity to consider the broader impact of gene patenting... [Read More]

US starts formal investigation into CRISPR patents

18 January 2016 - by Antony Blackburn-Starza

The CRISPR 'patent wars' have now officially kicked off in the USA, with formal proceedings to determine who controls key patents over the revolutionary genome-editing technology... [Read More]

Cancer patient appeals gene patenting decision

22 June 2015 - by Paul Waldron

Australia's highest court will decide whether isolated molecules of DNA linked to a gene mutation associated with an increased risk of hereditary breast and ovarian cancers are patentable under Australian law.... [Read More]

Advocate General paves the way for 'stem cell patents'

21 July 2014 - by Antony Blackburn-Starza

An advisor to the Court of Justice of the European Union (CJEU) has said that certain stem cells derived from unfertilised human eggs that have undergone parthenogenesis should not be excluded from patentability.... [Read More]

Podcast: Risk Management - Breast Cancer, Business and Patents

30 June 2014 - by James Brooks

Does the pharmaceutical and biotech industry's profit motive actually pervert rather than inspire innovation and the hunt for new therapies? Is the patent system well suited to a new life sciences landscape including stem cell and gene therapies?... [Read More]

Biotech vows to 'defend women's rights' by contesting Myriad lawsuit

23 June 2014 - by Alice Plein

Pathway Genomics, a biotech company based in San Diego, announced it will 'vigorously defend itself' against a patent infringement suit filed by Myriad Genetics and others... [Read More]

Risk Management: Breast Cancer, Business and Patents

09 June 2014 - by Simon Hazelwood-Smith

The backdrop to the third event in the Progress Educational Trust's 'Breast Cancer: Chances, Choices and Genetics' series was the Myriad Genetics gene patenting legal saga, which came to a conclusion last year with Myriad being denied a patent on the isolated forms of the BRCA genes... [Read More]

Breast cancer: breaking the chain

28 May 2014 - by Dr Ann Robinson

As a GP in North London, I see the ravaging effects of breast cancer in young women. Each patient sticks in my mind as their illness traumatises the whole family... [Read More]

Myriad sues companies for infringing on BRCA test patents

15 July 2013 - by Ruth Retassie

Myriad Genetics is suing two other companies who are offering genetic tests for BRCA1 and BRAC2 gene mutations for patent infringement... [Read More]

Human embryonic stem cell patent challenged

08 July 2013 - by Ari Haque

Two US public interest groups have asked a federal appeals court to hear a challenge of a patent over human embryonic stem cells... [Read More]

The sun still hasn't set on gene patents

01 July 2013 - by Dr Michael Hopkins and Dr Stuart Hogarth

Last week saw the conclusion of the long-running gene patent lawsuit known as AMP v. Myriad Genetics. At stake was the patentability of isolated DNA sequences... [Read More]

An historical turning point? The implications of the Myriad decision on the patentability of human genes

24 June 2013 - by Dr Linda Briceno Moraia and Dr Jane Kaye

The US Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics will have far-reaching implications, not just by lowering the costs of genetic tests, but also for the development of innovations in genetics and genomics and in other emerging fields such as stem cell research and synthetic biology.... [Read More]

US Supreme Court: Human DNA is a 'product of nature' and cannot be patented

17 June 2013 - by Dr Sarah Spain

The US Supreme Court has unanimously rejected a number of patent claims made by Myriad Genetics on isolated forms of two genes, BRCA1 and BRCA2, associated with an increased risk of breast and ovarian cancer.... [Read More]

Update to article: Fertility expert condemns 'outrageous' IVF cell cycle patent

03 June 2013 - by BioNews

A patent over a method for assessing cell-cycle data that can be used in IVF treatments to predict an embryo's future viability will make IVF treatments in the USA prohibitively expensive, a leading embryologist has said... [Read More]

Companies hold patents on entire human genome

08 April 2013 - by Ruth Saunders

A new study has reported that the entire human genome may be under patents held by commercial companies.... [Read More]

Patentability of isolated DNA in the Australian context: Cancer Voices Australia vs Myriad Genetics Inc

18 March 2013 - by Naomi Hawkins

Patents on human genes continue to cause controversy in the academic and popular press. A recent decision in Australia has reaffirmed the patentability of isolated human DNA in that jurisdiction... [Read More]

Myriad Genetics wins gene patent bid in landmark Australian ruling

18 February 2013 - by Matthew Thomas

A patent over a gene linked to hereditary breast and ovarian cancers is valid, an Australian federal court has ruled in a landmark case.... [Read More]

Fifty shades of Gray's Inn Road

03 December 2012 - by Sarah Norcross

The controversial issues discussed in BioNews aren't all black and white - fifty shades of grey is perhaps a more accurate description... [Read More]

Myriad Genetics holding genetic data as trade secrets

05 November 2012 - by Antony Blackburn-Starza

A group of academics has accused Myriad Genetics, the US biotech company that holds patents over the BRCA1 and BRCA2 genetic tests for increased risk of breast cancer, of keeping secret clinical data obtained from the tests by saying the information is commercially sensitive... [Read More]

US Supreme Court asked to reconsider gene patents

01 October 2012 - by Ruth Saunders

The American Civil Liberties Union has asked the US Supreme Court to reconsider its decision to uphold the patent held by Myriad Genetics on two human genes associated with hereditary breast and ovarian cancers... [Read More]


Events using this Glossary Item

No Events for this area at the moment.

Published by the Progress Educational Trust


Public Conference
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation